文献
J-GLOBAL ID:201802222795738390
整理番号:18A1350112
乳癌における2013年ASCO/CAP HER2報告ガイドラインの影響:特にIHC等音声カテゴリーに重点を置くHER2 IHCテストを主に実施するインド腫瘍センターからの評価研究【JST・京大機械翻訳】
Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category
著者 (9件):
Pasricha Sunil
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Gupta Gurudutt
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Garg Ritu
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Sharma Anila
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Gandhi Jatin S.
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Durga Garima
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Kamboj Meenakshi
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Grover Shrruti
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
,
Mehta Anurag
(Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India)
資料名:
Breast Journal
(Breast Journal)
巻:
24
号:
4
ページ:
468-472
発行年:
2018年
JST資料番号:
W2517A
ISSN:
1075-122X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)